Free Trial
LON:TRX

Tissue Regenix Group (TRX) Share Price, News & Analysis

Tissue Regenix Group logo
GBX 29.50 0.00 (0.00%)
As of 09:51 AM Eastern

About Tissue Regenix Group Stock (LON:TRX)

Key Stats

Today's Range
29.50
29.59
50-Day Range
29.05
36.40
52-Week Range
28.65
75
Volume
14,802 shs
Average Volume
54,241 shs
Market Capitalization
£26.60 million
P/E Ratio
N/A
Dividend Yield
4.12%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Tissue Regenix is a leading medical device company in regenerative medicine. The Company's patented decellularisation technology (dCELL®) removes DNA and other cellular material from animal and human soft tissue, leaving an acellular tissue scaffold not rejected by the patient's body that can be used to repair diseased or damaged body structures. Current applications address many crucial clinical needs in sports medicine, foot and ankle injuries, and wound care. In August 2017, Tissue Regenix acquired CellRight Technologies®. This biotech company specialises in regenerative medicine and is dedicated to developing high-quality, innovative tissue scaffolds to enhance healing opportunities in defects created by trauma and disease. CellRight's human tissue products may be used in spine, trauma, general orthopaedic, dental and ophthalmological surgical procedures.

Receive TRX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Tissue Regenix Group and its competitors with MarketBeat's FREE daily newsletter.

TRX Stock News Headlines

Tissue Regenix Scraps Sale Plans, Flags Profit Ahead
I was wrong about Trump
I made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his advisors, I believed him. I believed the promise that he would finally confront the single most dangerous threat to American life. That he would fix the ticking time bomb I’ve been warning about for 15 years. But I was wrong.
Tissue Regenix Group Regulatory News
Tissue Regenix Group Share Chat (TRX)
Tissue Regenix Group PLC (LSW.BE)
See More Headlines

TRX Stock Analysis - Frequently Asked Questions

Tissue Regenix Group's stock was trading at GBX 60 at the start of the year. Since then, TRX shares have decreased by 50.8% and is now trading at GBX 29.50.
View the best growth stocks for 2025 here
.

Tissue Regenix Group plc (LON:TRX) announced its quarterly earnings results on Wednesday, September, 2nd. The company reported ($0.16) earnings per share (EPS) for the quarter. Tissue Regenix Group had a negative trailing twelve-month return on equity of 2.87% and a negative net margin of 3.46%.

Shares of TRX stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

Based on aggregate information from My MarketBeat watchlists, some other companies that Tissue Regenix Group investors own include Lloyds Banking Group (LLOY), Argos Therapeutics (ARGSQ), FuelCell Energy (FCEL), TransEnterix (TRXDW), Swedbank (SWDBY), Trevena (TRVN) and Barrick Gold (ABX).

Company Calendar

Last Earnings
9/02/2020
Today
7/01/2025

Industry, Sector and Symbol

Stock Exchange
LON
Sector
Medical
Industry
Biotechnology
Sub-Industry
Precious Metals
Current Symbol
LON:TRX
CIK
N/A
Fax
N/A
Employees
120
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
58.74
P/E Growth
N/A
Net Income
-£1.11 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
£31.98 million
Cash Flow
GBX 5.18 per share
Price / Cash Flow
5.70
Book Value
GBX 41.58 per share
Price / Book
0.71

Miscellaneous

Free Float
N/A
Market Cap
£26.60 million
Optionable
Not Optionable
Beta
1.61
Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report

This page (LON:TRX) was last updated on 7/1/2025 by MarketBeat.com Staff
From Our Partners